Quest Diagnostics Incorporated Depreciation And Amortization for the Trailing 12 Months (TTM) ending June 30, 2025: USD 543.00 M

Quest Diagnostics Incorporated Depreciation And Amortization is USD 543.00 M for the Trailing 12 Months (TTM) ending June 30, 2025, a 19.87% change year over year. Depreciation and amortization are expense that reduces the value of tangible and intangible assets over their useful lives for tax and reporting purposes.
  • Quest Diagnostics Incorporated Depreciation And Amortization for the Trailing 12 Months (TTM) ending June 30, 2024 was USD 453.00 M, a 2.26% change year over year.
  • Quest Diagnostics Incorporated Depreciation And Amortization for the Trailing 12 Months (TTM) ending June 30, 2023 was USD 443.00 M, a 5.48% change year over year.
  • Quest Diagnostics Incorporated Depreciation And Amortization for the Trailing 12 Months (TTM) ending June 30, 2022 was USD 420.00 M, a 8.25% change year over year.
  • Quest Diagnostics Incorporated Depreciation And Amortization for the Trailing 12 Months (TTM) ending June 30, 2021 was USD 388.00 M, a 14.79% change year over year.
Key Data
Date Depreciation And Amortization Dividends Paid Common Stock Issued Common Stock Repurchased